Trials / Conditions / Leishmaniasis, Mucocutaneous
Leishmaniasis, Mucocutaneous
5 registered clinical trials studyying Leishmaniasis, Mucocutaneous — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | LEISH-PED: Study on Leishmaniasis in Children NCT07504757 | Meyer Children's Hospital IRCCS | — |
| Recruiting | Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly NCT06040489 | University of Brasilia | Phase 2 / Phase 3 |
| Completed | Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis NCT01377974 | Brasilia University Hospital | Phase 2 |
| Completed | Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis NCT00111514 | Access to Advanced Health Institute (AAHI) | Phase 1 |
| No Longer Available | Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis NCT00508963 | University of California, San Francisco | — |